CleanPath Resources Corp. announced that it has signed a marketing agreement to sell and distribute an innovative new product that causes the body to increase the production of stem cells. Having sufficient stem cells in the body potentially promotes self-repair and the ability to rejuvenate tissues from the skin to the heart, kidneys, pancreas, and liver.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -28.00% | 0.00% | -51.68% |
1st Jan change | Capi. | |
---|---|---|
-51.68% | 5.44M | |
-0.66% | 64.43B | |
+29.81% | 3.02B | |
-.--% | 2B | |
-23.80% | 787M | |
+30.28% | 682M | |
+3.90% | 575M | |
-8.27% | 379M | |
-5.94% | 331M | |
-8.67% | 239M |
- Stock Market
- Equities
- NTEI Stock
- News Nova Tech Enterprises, Inc.
- CleanPath Resources Corp. Signs Agreement to Market Stem Cell Activator